Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Strawberry Cough is a Sativa-dominant cannabis strain renowned for its distinct strawberry aroma and its tendency to induce coughing upon inhalation. It was originally bred by Kyle Kushman, reportedly from a cross between a North American Sativa and a strain called 'Strawberry Fields.' Pharmacologically, it exerts its effects primarily through the interaction of phytocannabinoids, such as delta-9-tetrahydrocannabinol (THC), with the G-protein coupled receptors of the endocannabinoid system, specifically the CB1 and CB2 receptors. It is frequently used in medicinal contexts for the management of stress, anxiety, and depression due to its uplifting and cerebral effects. The strain is also characterized by a specific terpene profile, including myrcene, pinene, and caryophyllene, which contribute to its therapeutic profile and aromatic properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Strawberry Cough.